title: Differentiating Chronic Lymphocytic Leukemia from Small Lymphocytic Lymphoma: A Manitoba Cancer Registry Perspective.
abstract: Monoclonal B-cell lymphocytosis (MBL) does not have a World Health Organization (WHO) International Classification of Diseases for Oncology (ICD-O) morphology code as it is not currently recognized as a reportable disease. Although MBL is premalignant, patients diagnosed with MBL need to be monitored as they eventually progress to chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Working together, the Manitoba CLL Disease Site Group (DSG) and the Manitoba Cancer Registry developed a way to record and track these patients to ensure they receive the proper follow-up care.
authors.forename: Angela
authors.initials: A
authors.lastname: Deneka
mesh_terms: D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000453:epidemiology / Q000473:pathology*; D008297:Male; D008350:Manitoba / Q000453:epidemiology; D012042:Registries